Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin with insulin in Japanese type 2 diabetes
NCT02081599Phase 4Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Jan 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Teneligliptin + Insulin with Placebo + Insulin → Teneligliptin + Insulin (2 arms). Primary endpoint: Hemoglobin A1c at 16 weeks. Started Jan 2014; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02081599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02081599.